How Type I Interferons Protect Latinos from Dangerous Viruses
Discover how Type I interferons power the body’s natural defense against dengue and other viruses, shaping Latino immunity and future therapies.
Read More
Ibuprofen vs. Fever: How Latin America Stays Cool
Fever is one of the body’s natural defenses against infection, but it can also cause fatigue, discomfort, and dehydration, especially during viral illnesses like dengue. Ibuprofen, one of the most trusted over-the-counter medications in Latin America, helps reduce fever and inflammation by blocking prostaglandins and resetting the body’s thermostat. Learn how this essential drug works and how to use it safely.
Puerto Ricans and Mexicans Face Greater Risk of Liver Disease from H. pylori
New research shows that H. pylori, a common stomach infection, may raise the risk of fatty liver disease in Hispanics, especially Puerto Rican and Mexican adults. With nearly half of participants affected, the study highlights the need for early screening and awareness in Latino communities already burdened by obesity and diabetes.
The Silent Threat of H. pylori in Hispanic Health
Helicobacter pylori (H. pylori) is more than just a stomach infection, it’s a hidden threat with serious consequences for Hispanic health. Beyond ulcers and gastritis, research shows links to gastric cancer, liver disease, and even metabolic disorders. Because Hispanic populations face higher infection rates, awareness, early detection, and treatment are critical in reducing long-term risks and improving overall health.
High Antibiotic Resistance Threatens H. pylori Treatment in Latin America
Rising antibiotic resistance is undermining H. pylori treatment in Latin America, with high resistance to metronidazole (53%) and clarithromycin (12%). Experts urge regional surveillance and recommend switching to regimens with lower resistance, like amoxicillin or tetracycline.
Is H. pylori Contagious? What You Need to Know
Affecting millions worldwide and hitting Hispanic and Latino communities hardest, this silent infection spreads easily in close living conditions. Knowing how H. pylori spreads is crucial to preventing infection and protecting your family.
Dengue Danger: Why Women Must Take Extra Precautions Now
Women in Latin America may face a higher risk of severe dengue due to biological, social, and behavioral factors. From pregnancy complications to increased mosquito exposure at home, the dangers are real. This post explores why women need extra protection, and the top three steps they can take to stay safe during dengue outbreaks.
Women Bear the Brunt of Latin America’s Dengue Surge
As Latin American women continue to lead in politics, science, and entrepreneurship, they face a quieter but growing threat: dengue. In 2024 alone, the region saw over 13 million dengue cases, with new research revealing that women, especially those of reproductive age, are more likely to suffer severe complications. From biological factors like estrogen’s impact on immunity to social roles that increase mosquito exposure, the gender gap in arboviral infections is real and urgent. With evidence mounting from countries like Brazil, experts are calling for gender-sensitive public health strategies, including targeted vector control, reproductive care, and expanded vaccine access to protect those most at risk.
Oropouche vs Dengue: Key Symptoms and Effective OTC Treatments Explained
Oropouche virus (OROV) and dengue virus (DENV) share overlapping symptoms like fever and headache, but key differences, such as sore throat and abdominal pain, can help with early diagnosis and effective treatment. This article breaks down the latest clinical findings, explores the biological mechanisms behind these symptoms, and recommends safe over-the-counter (OTC) remedies to manage discomfort without the risks of NSAIDs.
Think It’s Dengue? It Could Be Oropouche
New 2025 research reveals key differences between Oropouche fever and dengue virus infections. Learn how to spot predominant symptoms like sore throat and abdominal pain that can help distinguish OROV from DENV during outbreaks in Latin America.
How Climate Change Drives the Spread of Oropouche Virus in Latin America
As climate change reshapes ecosystems across Latin America, a silent viral threat is emerging: the Oropouche virus (OROV). Once confined to forested regions, OROV is now infecting thousands in urban centers—spread by tiny midges thriving in warmer, wetter environments. With no vaccine or treatment, and symptoms that mimic dengue, the virus is spreading under the radar. This article explores how deforestation, rising temperatures, and rapid urbanization are fueling OROV’s rise, and what must be done to stop it.
Climate Crisis Ignites Dengue Epidemic in Latin America
Climate change is fueling dengue outbreaks in Latin America. Learn how extreme heat and AI models in Brazil are reshaping global disease surveillance.